Please assess the completion status of the following clinical trial:

Trial Title: Efficacy and Safety of Topiramate in the Treatment of Sleep-Related Eating Disorder

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: EARLY_PHASE1
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Adults 18-65~* Diagnosis of SRED~* Must be able to swallow capsules and follow instructions~Exclusion Criteria:~* Women who are pregnant or lactating~* Other sleep disorders~* Kidney or Liver disease~* Night shift workers~* Previous history of Topiramate or Topamax use for any condition

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- Topiramate (Type: ACTIVE_COMPARATOR): Study medication arm, 25-300mg of Topiramate
- Placebo (Type: PLACEBO_COMPARATOR): Placebo arm of study, 25-300mg of sugar pill

Based on this trial design, predict the completion outcome and termination type (if applicable).